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Abstract
Background: Still increasing life expectancy in patients with implanted devices and large 
number of leads more and more often induce the need to cure the treatment complications or 
to change especially to cardiac resynchronization therapy (CRT). In order to prevent further 
complications, the possibility of damaged or redundant leads extraction should be taken into 
consideration. The aim of the paper was to assess the effectiveness and safety of transvenous 
lead extraction (TLE) with co-implantation of resynchronization systems.
Methods and results: Between 2008 and March 2013, the system removal with TLE was 
conducted in 246 patients. In 38 patients (11 women, 28.9%), aged 43–79 (mean 65 years), 
it was combined with co-implantation of CRT-pacemaker or defibrillator (CRT-P/D). Indica-
tions for TLE covered: lead failure in 21 (55.3%) patients, redundant leads in 6 (15.8%), and 
the occluded venous system in 7 (18.4%). The up-grade of the pacemaker or defibrillator system 
to CRT-D was performed in 19 cases, CRT-P/D revision in next 19. Together 32 defibrillation 
leads and 42 pacing leads (27 left ventricular leads, and 1 epicardial lead) were implanted. 
The intended clinical target — an effective resynchronization therapy — was obtained in all 
patients. There was no case of death or severe complications. In 2 cases of venous occlusion, 
the implantation on the contralateral side was required.
Conclusions: TLE enables effective resynchronization therapy also in the case of the presence 
of too many leads, occlusion of the venous system or lead failure. Significant technical problems 
can occur especially in patients with venous system occlusion. (Cardiol J 2015; 22, 2: 188–193)
Key words: lead extraction, cardiac resynchronization therapy, central venous 
occlusion, lead failure
Introduction
Increasing life expectancy in patients with 
cardiac implantable electronic devices and large 
number of leads in the venous system more and 
more frequently generate the need to cure the 
treatment complications or to change the therapy. 
It results from the primary disease progression 
as well as from expanding indications for more 
advanced form of therapy, e.g. automatic implant-
able cardioverter-defibrillator (ICD) or resynchro-
nization therapy (CRT) [1, 2]. In order to prevent 
further complications, the possibility of damaged 
or redundant lead extraction should be taken into 
ORIGINAL ARTICLE
Cardiology Journal 
2015, Vol. 22, No. 2, 188–193
DOI: 10.5603/CJ.a2014.0064
Copyright © 2015 Via Medica
ISSN 1897–5593
188 www.cardiologyjournal.org
Address for correspondence: Aleksander Maciąg, MD, PhD, 2nd Coronary Disease Department, Institute of Cardiology,  
ul. Spartańska 1, 02–637 Warszawa, Poland, tel: +48 22 343 40 50, fax: +48 22 844 95 10, e-mail: maciag_o@poczta.onet.pl
Received: 14.07.2014 Accepted: 05.08.2014
consideration in the case of longer life expectancy. 
Although in some patients adding the next lead can 
be taken into account, such proceeding could only 
postpone the problem and, in further perspective, 
mean the impairment of the system function. Ad-
ditionally, in case of the venous system occlusion, 
either on the level of subclavian vein, innominate 
vein or superior vena cava, which prevents a simple 
change of stimulation mode, the retrieval of the 
venous access is a reasonable alternative. Meeting 
these expectations constitutes a challenge for the 
operators performing transvenous lead extraction 
(TLE), since except for the lead extraction, which 
sometimes turns out very laborious itself, usu-
ally the equally demanding co-implantation of the 
resynchronization system should be conducted.
The aim of the paper was to assess the effec-
tiveness and safety of TLE with co-implantation of 
resynchronization systems.
Methods
Between 2008 and March 2013, the system 
removal with TLE was conducted in 246 patients 
in the clinic. In 93 (37.8%) patients, indications 
for the intervention were infectious complications 
such as pocket infection or infective endocarditis. 
The remaining 153 patients had non-infectious 
indications. Four hundred and seven leads were 
extracted in total. Data concerning patients, who 
had the lead extraction procedure combined with 
co-implantation of CRT-pacemaker or defibrillator 
(CRT-P/D) resynchronization system, were selected 
from the TLE procedures database for the need of 
the analysis. Table 1 shows patient proportion in 
particular years of keeping the registry. It is clearly 
visible that proportion of non-infected patients is 
gradually growing. Also, increasing CRT popula-
tion size corresponds with total patients group and 
operator’s experience. The selected CRT group 
equaled 38 (11 women, 28.9%), aged between 
43 and 79 (mean age 65) years. In the examined 
group, 23 patients had resynchronization system 
previously implanted (pacemaker in 5 cases, in the 
remaining 18 cases — cardioverter-defibrillator with 
resynchronization function), 9 patients had single or 
dual chamber pacing system and the rest of patients 
— single or dual chamber cardioverter-defibrillator. 
Table 2 presents clinical characteristics of the group.
All lead extraction procedures with co-implan-
tation of a new system were performed in the case 
of non-infectious indications. In 21 (55.3%) 
patients they were conducted due to lead damage, in 
6 (15.8%) — due to the necessity of the extraction 
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of leads that were not failed but redundant after the 
change of pacing mode, in 7 (18.4%) patients — due 
to the occlusion in venous system and necessity to 
restore the vascular access (in 2 cases — superior 
vena cava, in the remaining cases — subclavian and 
innominate vein), and due to the lead dislocation in 
further 4 (10.5%) cases. All patients had indications 
for the implantation of resynchronization system 
or for continuation of such therapy. The patient 
referred for the procedure in New York Heart 
Association (NYHA) class IV had cardiac competence 
deterioration due to left ventricular lead disloca-
tion and the loss of resynchronization stimulation.
Considering the complexity of the procedure 
and potential complications, the interventions were 
conducted in operating room or hybrid operating 
room conditions in order to provide cardiosurgical 
backup and safe general anesthesia process. Opera-
tions were performed under fluoroscopy. Patients 
with unsatisfactory escape rhythm were protected 
with temporary pacing lead from the femoral ap-
proach (6 patients, 15.8% of the study group).
Since the procedure objective was to perform 
the new lead implantation, the venous approach 
was provided through the catheter inserted to 
axillary or subclavian vein and the guide wire was 
advanced to the right atrium. If it was not possible 
due to venous occlusion or in the case of multiple 
lead implantation, the venous access was restored 
after lead extraction. If it was impossible to regain 
the access, the resynchronization system was im-
planted on the contralateral side.
In 1 case described previously it was indis-
pensable to use more advanced techniques to 
regain the venous system access [3]. In one of the 
patients, the adhesions between the lead and the 
vascular system were too weak to overcome the 
occlusion in the innominate vein with telescoping 
sheaths because the moderate traction caused com-
plete removal of the lead before the sheath reached 
the other side of the occlusion. In order to breach 
the occluded section of the vessel it was necessary 
to use the traction from femoral access, through 
the loop that was hooked on the next endocardial 
lead. Only such a method enabled to advance the 
telescopic sheaths to the right atrium (Fig. 1).
The lead extraction was conducted according to 
the method described above. The applied techniques 
were changed gradually from less aggressive to more 
complex ones, that is from the simple traction, through 
traction combined with the use of mechanical sheaths, 
to the use of rotating threaded tip sheaths [4, 5].
Most commonly used was the device traction 
— with mechanical telescopic sheaths — steel, 
Figure 1. Venous approach retrieval in patient with sub-
clavian vein occlusion. Vascular loop countertraction 
from femoral approach was used to tighten the atrial 
lead and to advance the vascular sheaths through the 
occlusion. The end of vascular loop (A), end of tele-
scopic sheath (B) as well as contrast extravasation after 
innominate vein dissection (C) are visible. 
Table 2. Clinical characteristics (n = 38).
Age [years] 65.4 (43–79) 
Female 11 (29%)
NYHA class:
II   11 (29%)
III  26 (68.5%) 
IV 1 (1.5%)
Primary disease/indication for implantation:
Post infarction HF 19 (50%)
Dilated cardiomyopathy 13 (34.2%)
Congestive HF caused by VHD 4 (10.5%)
Systolic dysfunction in HCM 2 (5.3%)
Indication for pacing:
AV heart block — IIo or IIIo 13 (34.2%)
Sick sinus syndrome 2 (5.3%)
Type of previously implanted device:
ICD with CRT 18 (47.4%)
Dual/single chamber pacemaker 9 (23.7%)
Dual/single chamber ICD 6 (15.7%)
Pacemaker with CRT 5 (13.2%)
NYHA — New York Heart Association; HF — heart failure; VHD —  
valvular heart disease; HCM — hypertrophic cardiomyopathy;  
AV — atrioventricular; ICD — implantable cardioverter-defibrillator; 
CRT — cardiac resynchronization therapy
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polypropylene or Teflon (Cook Vascular, Leech-
burg, PA, USA) twisted manually along the lead to 
cut the adhesions in the vascular system. The lead 
stiffness, with the lumen maintained, was obtained 
by means of a standard stylet or a locking stylet — 
Liberator Beacon (Cook Vascular, Leechburg, PA, 
USA) if necessary [6].
After the lead extraction, the remaining ones 
were assessed macroscopically in the available 
section and under fluoroscopy in the intravascular 
segment. Additionally, electrical parameters were 
controlled so that the leads could be used in the 
new system. They were extracted if they did not 
secure the safe system function.
Results
Sixty-three leads were extracted: 62 (98.4%) 
were extracted completely, in 1 (1.6%) case the 
clinical target was fully obtained, but the radio-
logical one was only partial — with a part smaller 
than 2 cm left inside. From 1 to 4 electrodes were 
extracted (mean 1.67 electrode per patient). The 
mean time from implantation to lead extraction 
equaled 56 months (from 6 to 194 months).
In total, 42 pacing leads (66.7%) and 21 (33.3%) 
defibrillating leads were extracted; out of those: 
34 (54%) leads had active fixation and 29 (46%) — 
passive fixation. Simple traction was effective in 
the case of 26 (41.3%) leads, device traction — in 
further 37 cases. From the number of 11 left ven-
tricular leads, implanted at an average 36.6 (58.3%) 
months earlier (14–69 months), 5 (45.5%) were 
extracted by means of simple traction and 6 (54.5%) 
by means of device traction. All of them were 
extracted undamaged. In patients with successful 
simple traction, the mean time from implantation 
to lead extraction was 24 months (from 6 to 108 
months), whereas in case of device traction — 
78 months (from 14 to 194 months).
Venous approach retrieval was not successful in 
2 out of 7 cases (28.6%) and resynchronization system 
implantation on the contralateral side was implanted.
The up-grade of single/dual chamber or biven-
tricular pacemaker, and cardioverter-defibrillator 
to CRT-D system was performed in 19 patients. 
In other patients, the revision of resynchronization 
systems was conducted — CRT-P in 1 case, in the 
remaining 18 — CRT-D, due to the damage of the 
leads or their dislocation. Figure 2 displays the 
types of implanted systems before lead extraction 
procedures and after new implantation.
New leads were implanted to coronary sinus 
system as well as to the right heart through previ-
ously secured vascular approach. In 1 patient, since 
it was impossible to implant left ventricular lead 
with acceptable electrical and hemodynamic effect, 
the left ventricular epicardial lead was implanted 
through lateral thoracotomy in co-operation with 
a cardiothoracic surgeon. It was connected with 
the device in the pocket in the left subclavian area. 
The total number of new implanted leads was as 
follows: 32 defibrillating leads, 42 pacing leads — 
including 27 left ventricular leads in the coronary 
sinus system and one epicardial lead.
The planned clinical target — effective resyn-
chronization therapy — was obtained in all patients.
The duration of the procedures and fluoros-
copy was not systematically noted for the whole 
study group, therefore it was not included into the 
statistical evaluation.
No case of death and no severe complications 
of the procedures such as periprocedural death, 
fatal avulsion of the heart or great vessels, em-
bolism or heart tamponade requiring emergency 
sternotomy were recorded.
Intraprocedural dissection of the innominate 
vein or superior vena cava with intramural he-
matoma occurred in 3 patients with innominate 
vein occlusion, but it did not require any surgical 
intervention. However, in 2 of those 3 patients it 
additionally hindered the new system implantation 
and it was necessary to implant the new system on 
the contralateral side.
In 1 patient, in the first 24 h, and in another 
one — on the 7th day following the implantation, 
the dislocation of right ventricular defibrillat-
ing lead was observed and it required system 
revision.
Figure 2. Types of implanted systems before lead ex-
traction as well as after the new implantation; CRT-D 
— implantable cardioverter-defibrillator with cardiac 
resynchronization therapy; CRT-P — pacemaker with 
cardiac resynchronization therapy; VVI/DDD — dual/ 
/single chamber pacemaker; ICD-VR/DR — dual/single 
chamber implantable cardioverter-defibrillator.
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Discussion
The clinical experience and current guidelines 
clearly indicate that the extraction of implanted 
systems with TLE in patients with systemic or local 
infection is undisputedly beneficial for the patients 
[7–12]. In the case of non-infectious indications, the 
benefits and consequently the indications are not 
unequivocal. Especially given the fact that some of 
them are not the electrotherapy complications but 
rather prevention of future complications [13–18]. 
There are no randomized clinical trials evaluating 
such a treatment, but there are new clinical data 
supporting this strategy [19]. The increasingly 
greater experience of the operators and growing set 
of tools allow to refer patients for such a therapy 
more boldly and on a wider scale, also in the case 
of patients with leads implanted many years earlier 
[4, 20]. It is visible even in the growing number of 
procedures (Fig. 1) and increasing percentage of 
non-infectious indications in the described registry 
as well as in larger groups of patients. In case of 
every patient the risk-benefit ratio is considered, 
including also the risk of alternative treatment and 
life expectancy [2, 21–23].
Taking into consideration the results of the 
published studies and the experience of our center, 
it seems that leaving no longer required and not 
working (6 items) or damaged (21 items) leads, 
in the majority of patients should be considered 
a palliative procedure. It would only mean the 
postponement of the lead extraction problem and 
in prospect the deterioration of function of the 
newly implanted, especially multi-lead systems. In 
such systems, one should anticipate a greater risk 
of lead interaction. It may result in lead insulation 
damage, which can not only deteriorate the lead 
function but also increase the infection risk in the 
future [13, 17, 18, 24].
In the case of patients with venous system 
occlusion (7 patients), which hinders the pacing 
mode change, one can consider the implantation of, 
e.g. the left ventricular lead from the alternative 
approach with tunnelization of the lead to primary 
pocket. Such treatment, despite its potential at-
tractiveness, can lead to loss of venous approach in 
the future and generate the necessity for epicardial 
stimulation. The above described procedure includ-
ing lead extraction in order to regain the venous 
approach is safe and creates the possibility of ef-
fective long-term transvenous stimulation even 
in spite of occurring technical problems [25–29].
A particular case of venous occlusion obstruct-
ing the system development is the occlusion of 
superior vena cava. Sometimes it appears shortly 
after implantation with sufficient venous drainage 
via the collateral circulation, mainly through the 
azygos vein, and often remains asymptomatic. 
Alternative central venous approach in such pa-
tients is basically limited only to femoral approach. 
Venous access retrieval, sometimes with the loss of 
the working lead, enables successful implantation. 
Often the countertraction from femoral approach 
as well as long, measuring over 20 cm, peel-away 
introducers have to be used in such procedures 
[3, 25, 26].
A substantial parameter evaluating the quality 
of patient care is the occurrence of applied therapy 
complications. In spite of the lack of complications 
that would require cardiovascular surgical inter-
vention in this group, special attention should be 
paid to the dissection of vessels with intramural 
hematoma sometimes present in patients with 
venous occlusion. Such complication appears in 
the place where the lead sticks to the wall of the 
blood vessel, especially where the subclavian and 
jugular vein as well as superior vena cava and the 
atrium amalgamate. To avoid extraction of the 
lead before overcoming the occlusion, the applied 
tension is not strong enough, which results in the 
vessel wall destruction by the telescopic sheath. 
This complication remained clinically silent in the 
study group and was discovered in venography 
performed after the unsuccessful attempt of insert-
ing the guide wire. It seems that it can be present 
in more cases but it is not identified unless the 
intraprocedural venography is performed. Greater 
lead tension, which allows to avoid the premature 
lead extraction, but also too much pressure put on 
the vessel wall, can be obtained by captivating the 
lead in the intracardiac part with the stylet inside 
it. Such method led to successful venous approach 
retrieval in 1 patient from the study group.
Limitations of the study
In unicenter registry, the decisions concern-
ing the therapy depend to a significant extent on 
the experience of the Heart Team referring for 
such procedures and the way they interpret the 
guidelines, which may affect the group selection.
The small number of patients in the study 
group may limit the chance of encountering rare 
but statistically relevant complications such as 
tamponade, embolization or heart tear.
The lack of comprehensive data concerning 
the duration of the procedures and fluoroscopy does 
not allow to present all data showing indirectly the 
level of complexity of such procedures.
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Conclusions
Transvenous lead extraction enables obtain-
ing effective resynchronization stimulation even 
in the case of excessive number of leads, venous 
system occlusion after previous implantation or 
lead damage in resynchronization systems even 
despite considerable technical problems, especially 
in patients with venous system occlusion.
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